The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug middlemen are marking up the prices of specialty generic drugs dispensed at their affiliated pharmacies by hundreds—and in some cases, thousands—of percent...
|
Scooped by
Anonymous Hades
onto Backstabber Watch January 15, 9:34 AM
|